Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.74 SEK | +4.72% | +8.86% | +13.51% |
Apr. 18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
Apr. 18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.51% | 143M | |
+24.64% | 48.09B | |
+46.90% | 40.62B | |
-3.17% | 40.43B | |
-6.20% | 28.36B | |
+9.39% | 24.89B | |
-20.36% | 19.01B | |
+28.59% | 12.09B | |
+0.64% | 11.88B | |
-1.21% | 11.8B |
- Stock Market
- Equities
- HNSA Stock
- News Hansa Biopharma AB
- Hansa Biopharma's Follow-up Study Shows High Survival Rate for Imlifidase-enabled Kidney Transplant Patients